Biosight

Developer of therapeutics for oncology & hematological disorders

placeKarmiel, North District, Israel calendar_todayFounded 2000 groups10 employees language biosight-pharma.com

Innovation

17 patent families (8 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 774 times.

YearFilings
20122
20131
20151
20162
20173
20182
20193
20201
20217
20226
20239
20247

Investor mix

10 investors on record; lead investors include Arkin Holdings, Israel Biotech Fund, Primera Capital, Ilan Holdings.

Investor typeCountShare
Venture capital660%
Private equity110%
Other / undisclosed330%
Coming soon